Factor VIII concentrates

DRUG2 trials

Sponsors

New York Presbyterian Hospital, Hoffmann-La Roche

Conditions

Hemophilia A With InhibitorsVon Willebrand Disease, Type 3

Unknown Phase

International Immune Tolerance Study

TerminatedNCT00212472

New York Presbyterian HospitalHemophilia A With Inhibitors

Start: 2002-07-31End: 2012-12-31Updated: 2009-12-07

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

RecruitingNCT06883240

Hoffmann-La RocheVon Willebrand Disease, Type 3

Start: 2025-04-29End: 2026-11-01Target: 40Updated: 2026-03-18